- Benchmark ASINB0G4R5DYX8
- MarketplaceUS
- Category ID3760901
- Analyzed Products
- Keywordinsulin travel case, insulin organizer case, diabetic supplies travel case
- Price Range-
- Minimum Net Profit Margin10.00%
- MOQ100
- Est. Purchasing CostNo price data
- Data Date2026-07-27
- Your Budget (for new listing) (CNY)¥500,000.00
Report summary from Keble AI Agent: Listing
这个市场不建议进入，结论明确：已经是价格战+同质化的红海，新品牌和小商家都没有稳定窗口。 现有数据里，新品牌总共8个、总新发布25个，只有6个真正跑出盈利，成功率24.00%；但一旦放大到全部新发布，盈利率只有19.51%，说明大多数新品都没跑通。更关键的是，最近一批新品里大量落在低利润或亏损区，市场正在往更激烈的竞争方向走，不是变好。
Recommended Products Features Direction
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
New Brands
VS
Old Brands
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
New Brands
Old Brands
#Budget Requirement
Listing不建议进入，这个市场已经明显进入价格战区，且对新入场者不友好。 你的预算 500,000 CNY 约等于 70,000+ USD，表面上足够覆盖单个新品的前期投入，但市场里大多数新品利润并不稳，靠常规打法很难跑出来，尤其小商家几乎没有安全窗口。
从数据看，市场新品可盈利率只有 19.51%，整体可盈利率也只有 16.88%，说明大多数产品都不赚钱；更关键的是，新品牌新品的非盈利率高到 72.00%，老品牌新品的非盈利率也有 87.50%，而且样本里只有少数新品牌在赚钱。当前能作为正面标杆的新品牌只有 vamctry、Mazentrix、Krypthos，其中 vamctry 的可识别利润产品 2 个、不可盈利产品 9 个，整体并不稳；真正能直接参考的成功款包括 B0GZ6N4Q77（约 $1,834 启动预算，利润率 16.71%，月销 1,750，月营收约 $25.24k）和 B0FWS2TWL7（利润率未给出但为盈利款，月销 200，月营收约 $2.16k）；老品牌里 YOUSHARES 的代表款 B0F6VH6DHD 约 15.06% 利润率、月销 8,000、月营收约 $127.6k，但它是老品牌资源盘，不适合作为小商家模板。相反，失败样本里 B0GSYMRGP2 的利润率是 -35.06%，而 B0GZ4RHPR1 只有 3.06%，都属于很危险的低利润/亏损款。
结论很直接：大品牌勉强可以靠更高预算和品牌力试，但小商家不适合进。 你的预算虽然够启动，但不足以覆盖长期品牌、研发和认证成本；如果硬要做，大品牌只能跟 YOUSHARES / vamctry / Krypthos 这种已经验证过有销量和利润的款型走，重点看 B0F6VH6DHD、B0GZ6N4Q77、B0FWS2TWL7、B0G4R5DYX8。小商家不要把老品牌当模板，真正能参考的“轻量成功”也只有 B0GZ6N4Q77 和 B0FWS2TWL7 这类新品牌盈利款，但它们已经在靠差异化和投放吃市场；如果你没有更强差异化或更低成本结构，这个市场不值得进。
Early sourcing + logistics + marketing budget (USD)$3,901.56 - $13,248.60Explains the budgetWith all these investments, who has profitable new releases
How many new listings are released by old brands?39.02%New listing success rate (old brands):12.50%New listing success rate (new brands):24.00%Which new brands have these successful new listings?Which old brands have these successful new listings?Alternatives- 普通硬壳眼镜盒或便携收纳盒：尺寸小、价格通常更低，适合临时装几支胰岛素笔芯/小瓶和酒精棉片，用户改造成本低。
- 药盒/分隔式小药包：不专门针对胰岛素，但在家中或短途出行时可用来分装针头、棉签、采血针等小件，获取门槛低、几乎随处可买。
- 拉链文具收纳袋：作为更便宜的“临时替代”，可放入胰岛素相关小配件、说明书和备用耗材；轻便且选择多，适合预算敏感用户。
- 小型电子配件收纳包（线材包/充电器包）：内部网袋和弹性绑带结构接近，能更容易固定试纸、针头、笔帽等零散物品，通常比专用糖尿病旅行盒更便宜。
- 午餐保冷袋/迷你保温袋：如果用户核心诉求是短时保冷而非强组织收纳，这类产品更容易买到，也常可兼顾冰袋与耗材一起携带。
- 一次性密封袋 + 便携硬盒组合：用小密封袋分开装针头、棉片、备用电池，再放入普通硬盒里，成本最低、灵活度高，适合偶尔出行人群。
Alternative solutions may pose a risk to your investment in certain markets.
#Brands Investment Analysis
Listing这不是一个适合进入的市场。 数据显示市场已经明显偏向价格战和同质化竞争：整体利润分布里，0%~10%利润段有22个样本，10%~20%只有12个，新品里也只有8个低于10%、7个在10%~20%，说明能赚钱的不是没有，但大多数都卡在很薄的利润带里；同时新品牌新品盈利率只有24.00%，亏损/未成功新品高达72.00%，而旧品牌新品亏损/未成功率更高到87.50%，这是一个高竞争、低容错的市场，不适合把它当成稳妥赛道。 关键证据：新品牌里，vamctry 11个产品只拿到2个盈利，9个亏损/不盈利；FNANJWQ 1个新品直接亏损，0个盈利；YOUSHARES 14个产品里只有1个盈利，13个亏损。更重要的是，真正能站住的样本都靠明显改款，不是靠普通软包同质化：Mazentrix 的 B0FWS2TWL7（10格硬壳、$10.79、月销2158）、B0GJSHCJY6（10格、$13.20、月销13200）和 B0GZ6N4Q77（15格、$14.42、月销25235）都属于“基于旧款做功能/容量差异化”；反过来，像 vamctry 的 B0GZ4RHPR1（$12.77，利润率3.06%）、B0GZ4PB91H（$10.49）和 FNANJWQ 的 B0GSYMRGP2（$5.68，利润率-35.06%）都直接掉进低利润或亏损区。结论很直接：如果你是小卖家，不建议进；如果是大品牌，才有可能靠预算、品牌和研发去硬推，但也只是“可能”，不是高胜率。
Least investment in new productsNew products with Highest revenueMost investment in new productsvamctry
Recent Monthly Revenue (USD):$25,235.00(1750pcs/month)B0GZ6N4Q77 (4.8/5 (186 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitable
Recent Monthly Revenue (USD):$13,200.00(1000pcs/month)B0GJSHCJY6 (4.8/5 (139 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQBlack HatThis listing is deemed profitableOld brand with the most profitable new productsYOUSHARES
Recent Monthly Revenue (USD):$127,600.00(8000pcs/month)B0F6VH6DHD (4.6/5 (1449 Reviews))Brand is an old entry in this marketOld ReleaseSufficient Sales to Meet MOQOld ReleaseThis listing is deemed profitableLeast profitable new productsFNANJWQ
Recent Monthly Revenue (USD):-(-)B0GSYMRGP2 (5/5 (2 Reviews))Brand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQ#Differentiations
Unique productsCommon productsDifferentiation:- 黑色硬壳+透明上盖，外观和常见软包明显不同
- |
- 28格大容量分区，更适合多支胰岛素瓶整理
- |
- 兼顾冰箱收纳和外出携带，功能场景更特别
- |
- 适合需要精细分类存放的糖尿病用户
B0G4R5DYX8 (4.8/5 (329 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitableSales & BSR
Differentiation:- 15个独立分格，结构比常见基础款更有区分度
- |
- 兼容1ml到30ml多种药瓶，适用范围更广
- |
- 既能放冰箱也方便外出，实用性强
- |
- 紧凑便携，适合需要统一收纳多种小药瓶的人群
B0GZ6N4Q77 (4.8/5 (186 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitableSales & BSR
#Net Profit Margins: All vs New
Listing这个市场不适合现在进入：它已经进入明显的价格战区，且新品牌成功率不够稳。 目前新上架产品里只有19.51%达到可接受盈利，市场利润中位区间只有-0.13%到17.30%，而且新增品牌共有8个、总新发布41个，竞争已经很拥挤；对新卖家来说，想靠普通同质化款切入，风险很高。
Profitability difficultyModerate Risk Due to Price CompetitionAll products distribution on different profit levels
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%otherNew products distribution on different profit levels
This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'
x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%other#Top Products by Net Profit Margin
Top 20 Profitable Products
Most profitable products ranked by profit value. Only includes products with positive profitability and active sales, regardless of release date.
B0F6VH6DHDYOUSHARES2025-04-29Yes$15.958000pcs$127600.015.06%$19216.57B0GZ6N4Q77vamctry2026-06-07Yes$14.421750pcs$25235.016.71%$4216.77B0GJSHCJY6vamctry2026-04-28Yes$13.21000pcs$13200.014.38%$1898.17B0G4R5DYX8Krypthos2026-01-07Yes$21.99200pcs$4398.020.03%$880.92
B0FKS3BY8KMazentrix2025-08-14Yes$13.65300pcs$4095.018.44%$755.12
B0FPM9QGWHTeenyyou2025-09-03Yes$14.91250pcs$3727.518.74%$698.54
B0DZXHG35QTeenyyou2025-03-10Yes$14.46250pcs$3615.018.01%$651.07
B0F194XTR7Teenyyou2025-03-12Yes$14.34250pcs$3585.017.09%$612.68
B0FMF9XCJWMazentrix2025-08-14Yes$16.17200pcs$3234.016.39%$530.06
B0FPMBC7YDTeenyyou2025-09-03Yes$14.52200pcs$2904.018.06%$524.47
B0DSHRLG7PTeenyyou2025-01-08Yes$14.73200pcs$2946.014.05%$413.92
B0FWS2TWL7Mazentrix2025-10-17Yes$10.79200pcs$2158.011.23%$242.35
B0FHGM92Y2Nomatox2025-07-14Yes$13.850pcs$690.010.75%$74.18Top 20 Profitable New Products
Most profitable new products ranked by profit value. Only includes newly released products with positive profitability and active sales.
B0GZ6N4Q77vamctry2026-06-07Yes$14.421750pcs$25235.016.71%$4216.77B0GJSHCJY6vamctry2026-04-28Yes$13.21000pcs$13200.014.38%$1898.17B0G4R5DYX8Krypthos2026-01-07Yes$21.99200pcs$4398.020.03%$880.92B0FKS3BY8KMazentrix2025-08-14Yes$13.65300pcs$4095.018.44%$755.12B0FPM9QGWHTeenyyou2025-09-03Yes$14.91250pcs$3727.518.74%$698.54B0FMF9XCJWMazentrix2025-08-14Yes$16.17200pcs$3234.016.39%$530.06B0FPMBC7YDTeenyyou2025-09-03Yes$14.52200pcs$2904.018.06%$524.47B0FWS2TWL7Mazentrix2025-10-17Yes$10.79200pcs$2158.011.23%$242.35#New Product Success Rates
Listing这个市场不值得进入，已经明显偏向红海且价格战很重。 新品牌并非完全没机会，但真正能赚钱的只有少数，且多数新上架产品亏损，说明小品牌靠常规款很难稳定胜出。
New products success rate.
What is the ratio of profitable products
Profitable (Unidentifiable released date)Profitable (Old product)Profitable (New product)Profitable (New product on old listing)New products but non profitableProfitable new products divide by brands
What is the ratio of different brands owning all profitable new products
vamctryMazentrixTeenyyouKrypthosNonprofitable new products divide by brands
What is the ratio of different brands owning all nonprofitable new products
vamctryYOUSHARESTeenyyouOther#Success Rate by Entry Time
Listing这个市场不适合现在进入，结论是偏向放弃。 近一年新品牌大量涌入，但成功率明显偏低，2026 年新发布里失败占多数，市场已经进入明显的竞争加速期，不是好切入点。
How many products released each year
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
How many products released each month
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
#Net Profit Margins by Entry Time
Different profit ratios of products released in year
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2022 0 0 0 0 0 0 0 0 2023 0 0 0 0 0 0 0 0 2024 0 0 0 0 0 0 0 0 2025 0 1 1 5 0 0 0 6 2026 0 0 7 2 1 0 0 18 ≥ 10% Profitable< 10% UnprofitableUnidentifiableDifferent profit ratios of products released in month
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2025/7 0 0 0 0 0 0 0 0 2025/8 0 0 0 2 0 0 0 2 2025/9 0 0 1 2 0 0 0 1 2025/10 0 0 0 1 0 0 0 1 2025/11 0 0 0 0 0 0 0 2 2025/12 0 1 0 0 0 0 0 0 2026/1 0 0 0 0 1 0 0 2 2026/2 0 0 0 0 0 0 0 1 2026/3 0 0 2 0 0 0 0 3 2026/4 0 0 0 1 0 0 0 8 2026/5 0 0 2 0 0 0 0 1 2026/6 0 0 3 1 0 0 0 2 ≥ 10% Profitable< 10% UnprofitableUnidentifiable#Case Study
Success CasesMazentrixB0FKS3BY8K (4.7/5 (228 Reviews))Mazentrix Peptide Vial Case for Fridge Storage - 30 Slots Organizer Holds 1-3ml Vials for Insulin, GLP-1, Peptides,Hard Shell Travel Case with Hand Strap,Black (Black-30 Slots)
This listing is deemed profitablePrice (USD)$13.65Released TypeNew Release (2025-08-14)Brand is a new entry in this marketSize and Weight16.6 x 12.6 x 5.4 cm, 120.00gProfitable Factors
Based on old ASINDistinct functions and featuresUnique appearance designDesign & Appearance
黑色硬壳更偏向专业、低调的医疗收纳风格, 30位槽位的硬壳收纳盒，整体更像高密度内衬分隔式工具盒，而不是普通软包Key Buying Motive
主打1–3ml小药瓶固定收纳，并兼顾冰箱/冷冻储存与外出携带Target Customers
需要同时满足家用冰箱收纳与短途随身携带的胰岛素/GLP-1/肽类用药用户Early Investment
Investment
Monthly Revenue (Recent) (USD)$4,095.00300 sold in the past 30 days · as of 2026年7月Net Profit Margin
Sea Freight15.11% / 18.44%Peak / Non PeakRail Freight- / -Peak / Non PeakAir Freight8.39% / 11.72%Peak / Non PeakSales & BSR Performance
MazentrixB0FMF9XCJW (4.7/5 (228 Reviews))Mazentrix Peptide Vial Case for Fridge Storage - 63 Slots Organizer Holds 1-3ml Vials for Insulin, GLP-1, Peptides,Hard Shell Travel Case with Hand Strap,Black (Black-63 Slots)
This listing is deemed profitablePrice (USD)$16.17Released TypeNew Release (2025-08-14)Brand is a new entry in this marketSize and Weight21.9 x 18.1 x 5.4 cm, 191.00gProfitable Factors
Based on old ASINDistinct functions and featuresDesign & Appearance
黑色外观，偏专业医疗收纳风格, 63个槽位的大容量硬壳分层收纳结构，适合冰箱内整齐摆放Key Buying Motive
兼顾冰箱/冷冻存放与外出携带，适合1-3ml小瓶分格固定Target Customers
需要长期冷藏管理胰岛素、GLP-1或肽类小瓶的糖尿病/注射治疗用户Early Investment
Investment
Monthly Revenue (Recent) (USD)$3,234.00200 sold in the past 30 days · as of 2026年7月Net Profit Margin
Sea Freight12.32% / 16.39%Peak / Non PeakRail Freight- / -Peak / Non PeakAir Freight1.57% / 5.63%Peak / Non PeakSales & BSR Performance
Loading samples... 25%